HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decrease in 4-aminobiphenyl-induced methemoglobinemia in Cyp1a2(-/-) knockout mice.

Abstract
Methemoglobin formation, as well as hemoglobin or DNA adducts, are useful biomarkers of occupational exposure to certain arylamines. It has been suggested that, in liver from animals not treated with a cytochrome P450 (CYP) inducer, hepatic CYP1A2 is the major P450 involved in N-hydroxylation. This is the first step in the metabolic activation of many arylamines, such as the human urinary bladder carcinogen 4-aminobiphenyl (ABP). The product of this catalytic step, N-hydroxy-4-ABP, reacts in the blood with oxyhemoglobin to form methemoglobin and nitrosobiphenyl. We therefore examined the role of CYP1A2 in causing methemoglobinemia in ABP-treated Cyp1a2(-/-) knockout mice. Application of ABP (100 micromol/kg body wt) to the skin resulted in a marked depletion in the levels of the hepatic thiols (reduced glutathione and cysteine) after 2 h, which rebounded to basal levels 24 h later, and we found no differences between the Cyp1a2(-/-) and wild-type Cyp1a2(+/+) animals. Unexpectedly, the methemoglobin levels were significantly (p < 0.05) higher in Cyp1a2(-/-) than Cyp1a2(+/+) mice at 2, 7, and 24 h following topical ABP. Treatment with dioxin, 24 h prior to ABP, decreased methemoglobin levels by about half at each of the time points in both the Cyp1a2(-/-) and Cyp1a2(+/+) mice. These data suggest that CYP1A2 does not play a positive role in methemoglobin formation via the activation of ABP; rather, the absence of CYP1A2 enhances ABP-induced methemoglobinemia. Because liver CYP1A2 levels are known to vary more than 60-fold between humans, our findings may be relevant to patients who are exposed to arylamines in the workplace.
AuthorsHoward G Shertzer, Timothy P Dalton, Glenn Talaska, Daniel W Nebert
JournalToxicology and applied pharmacology (Toxicol Appl Pharmacol) Vol. 181 Issue 1 Pg. 32-7 (May 15 2002) ISSN: 0041-008X [Print] United States
PMID12030840 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Copyright(c) 2002 Elsevier Science (USA).
Chemical References
  • Aminobiphenyl Compounds
  • Biomarkers
  • Carcinogens
  • Polychlorinated Dibenzodioxins
  • 4-biphenylamine
  • Cytochrome P-450 CYP1A2
  • Glutathione
  • Cysteine
Topics
  • Administration, Topical
  • Aminobiphenyl Compounds (administration & dosage, metabolism, toxicity)
  • Animals
  • Biomarkers
  • Biotransformation
  • Carcinogens (administration & dosage, metabolism, toxicity)
  • Cysteine (metabolism)
  • Cytochrome P-450 CYP1A2 (genetics, metabolism)
  • Disease Models, Animal
  • Glutathione (metabolism)
  • Liver (drug effects, metabolism)
  • Methemoglobinemia (chemically induced, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Occupational Exposure
  • Polychlorinated Dibenzodioxins (metabolism, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: